Erdafitinib in Patients With Advanced Solid Tumors With <i>FGFR</i> Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts

Omar Carranza, Shubham Pant, Martin Schuler, Olaf Witt, Birgit Geoerger, Yohann Loriot, Sameer Farouk Sait, Dirk Arnold, Graziela Z. Dal Molin, Iwona Lugowska, Helen Winter, Capucine Baldini, Marcelo Corassa, Shibu Thomas, Lauren Crow, Yichuan Xia, Spyros Triantos, Hussein Sweiti, David A. Reardon

Open source

DOI: 10.1200/po-25-01094
Published: 2026-07
Container: JCO Precision Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/po-25-01094,
  title = {Erdafitinib in Patients With Advanced Solid Tumors With
                    <i>FGFR</i>
                    Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts},
  author = {Omar Carranza and Shubham Pant and Martin Schuler and Olaf Witt and Birgit Geoerger and Yohann Loriot and Sameer Farouk Sait and Dirk Arnold and Graziela Z. Dal Molin and Iwona Lugowska and Helen Winter and Capucine Baldini and Marcelo Corassa and Shibu Thomas and Lauren Crow and Yichuan Xia and Spyros Triantos and Hussein Sweiti and David A. Reardon},
  year = {2026},
  journal = {JCO Precision Oncology},
  doi = {10.1200/po-25-01094},
  url = {https://doi.org/10.1200/po-25-01094}
}

RIS

TY  - JOUR
TI  - Erdafitinib in Patients With Advanced Solid Tumors With
                    <i>FGFR</i>
                    Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts
AU  - Omar Carranza
AU  - Shubham Pant
AU  - Martin Schuler
AU  - Olaf Witt
AU  - Birgit Geoerger
AU  - Yohann Loriot
AU  - Sameer Farouk Sait
AU  - Dirk Arnold
AU  - Graziela Z. Dal Molin
AU  - Iwona Lugowska
AU  - Helen Winter
AU  - Capucine Baldini
AU  - Marcelo Corassa
AU  - Shibu Thomas
AU  - Lauren Crow
AU  - Yichuan Xia
AU  - Spyros Triantos
AU  - Hussein Sweiti
AU  - David A. Reardon
PY  - 2026
JO  - JCO Precision Oncology
DO  - 10.1200/po-25-01094
UR  - https://doi.org/10.1200/po-25-01094
ER  -

APA

Carranza, O., Pant, S., Schuler, M., Witt, O., Geoerger, B., Loriot, Y., Sait, S. F., Arnold, D., Molin, G. Z. D., Lugowska, I., Winter, H., Baldini, C., Corassa, M., Thomas, S., Crow, L., Xia, Y., Triantos, S., Sweiti, H., & Reardon, D. A. (2026). Erdafitinib in Patients With Advanced Solid Tumors With <i>FGFR</i> Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts. JCO Precision Oncology. https://doi.org/10.1200/po-25-01094

Source records

crossref · retrieved 2026-09-27T03:10:12.445Z